This website uses cookies. By continuing to use this website, you consent to our use of these cookies. Read more about our use of cookies.
WE CARE ABOUT RARE DISEASE PATIENTS
Sobi is dedicated to developing and delivering innovative therapies to improve the lives of rare disease patients.
North America News
Sobi Receives Approval from Health Canada for Once-Daily Dosing of Orfadin® (nitisinone) for the Treatment of HT-1
Our Products
Sobi’s product portfolio is primarily focused on inflammation and genetic diseases.
Global News
Sobi emphasises commitment to haemophilia community at WFH 2018 World Congress
Sobi United States Office
890 Winter Street
Waltham, MA 02451, USA
Sobi Canada Office
1155 North Service Rd. West, Unit #11
Oakville, Ontario, Canada L6M 3E3